GHK-Cu prepares a healthier scalp environment by reducing DHT, increasing blood supply, and calming inflammation
Both medications contain semaglutide, but they are FDA-approved for different uses
Anecdotally, some users report experiencing gastrointestinal issues like nausea, diarrhea, or constipation, as well as headache, fatigue, or irritation at the injection site
Risks, Side Effects, Long-Term Safety, and Unknowns Short Answer: BPC-157 safety is not well established in humans
(9) The noted wide effectiveness in all of these models postulates a quite general wound healing effect (8) BPC-157 reduced inflammation and tissue death, and promoted skin regrowth in mice with severe burns